Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2010. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically detailing changes in their interests in the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to disclosure of specific share transactions and does not contain financial statements or performance metrics.
Material Changes
The filing reports the following share purchases by company insiders on February 5, 2010:
- Mr. A P Witty: Purchased 8,193 ordinary shares at a price of £12.12 per share.
- Mr. S M Bicknell: Purchased 1,000 ordinary shares at a price of £12.12 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory notification of director share transactions under Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Two directors purchased shares on the same day at the same price (£12.12).
- The total number of shares purchased by these two individuals was 9,193.
- The transactions were notified to the company on February 5, 2010.
- This filing does not contain financial performance data for the period.